Literature DB >> 24550298

Ischemic neurons recruit natural killer cells that accelerate brain infarction.

Yan Gan1, Qiang Liu, Wei Wu, Jun-Xiang Yin, Xue-Feng Bai, Rulong Shen, Yongjun Wang, Jieli Chen, Antonio La Cava, Jennifer Poursine-Laurent, Wayne Yokoyama, Fu-Dong Shi.   

Abstract

Brain ischemia and reperfusion activate the immune system. The abrupt development of brain ischemic lesions suggests that innate immune cells may shape the outcome of stroke. Natural killer (NK) cells are innate lymphocytes that can be swiftly mobilized during the earliest phases of immune responses, but their role during stroke remains unknown. Herein, we found that NK cells infiltrated the ischemic lesions of the human brain. In a mouse model of cerebral ischemia, ischemic neuron-derived fractalkine recruited NK cells, which subsequently determined the size of brain lesions in a T and B cell-independent manner. NK cell-mediated exacerbation of brain infarction occurred rapidly after ischemia via the disruption of NK cell tolerance, augmenting local inflammation and neuronal hyperactivity. Therefore, NK cells catalyzed neuronal death in the ischemic brain.

Entities:  

Keywords:  innate immunity; ischemic stroke; middle cerebral artery occlusion

Mesh:

Substances:

Year:  2014        PMID: 24550298      PMCID: PMC3932858          DOI: 10.1073/pnas.1315943111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro.

Authors:  E Backström; B J Chambers; K Kristensson; H G Ljunggren
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

2.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.

Authors:  J D Young; H Hengartner; E R Podack; Z A Cohn
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

4.  Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Authors:  F D Shi; H B Wang; H Li; S Hong; M Taniguchi; H Link; L Van Kaer; H G Ljunggren
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

5.  Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus.

Authors:  T M Shieh; D L Carter; R L Blosser; J L Mankowski; M C Zink; J E Clements
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

6.  Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.

Authors:  Eva Backström; Benedict J Chambers; Emily L Ho; Olga V Naidenko; Raffaella Mariotti; Daved H Fremont; Wayne M Yokoyama; Krister Kristensson; Hans-Gustaf Ljunggren
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

Review 7.  Neuroprotective mechanisms of hypothermia in brain ischaemia.

Authors:  Midori A Yenari; Hyung Soo Han
Journal:  Nat Rev Neurosci       Date:  2012-02-22       Impact factor: 34.870

8.  Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat.

Authors:  Glauco Tarozzo; Marilena Campanella; Michela Ghiani; Alessandro Bulfone; Massimiliano Beltramo
Journal:  Eur J Neurosci       Date:  2002-05       Impact factor: 3.386

9.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

10.  Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.

Authors:  J Hackett; M Tutt; M Lipscomb; M Bennett; G Koo; V Kumar
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

View more
  111 in total

1.  Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation.

Authors:  Qiang Liu; Nader Sanai; Wei-Na Jin; Antonio La Cava; Luc Van Kaer; Fu-Dong Shi
Journal:  Nat Neurosci       Date:  2016-01-11       Impact factor: 24.884

2.  Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.

Authors:  Wei-Na Jin; Andrew F Ducruet; Qiang Liu; Samuel Xiang-Yu Shi; Michael Waters; Ming Zou; Kevin N Sheth; Rayna Gonzales; Fu-Dong Shi
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

3.  Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition.

Authors:  Baokai Dou; Shichun Li; Luyao Wei; Lixin Wang; Shiguo Zhu; Zhengtao Wang; Zunji Ke; Kaixian Chen; Zhifei Wang
Journal:  Front Med       Date:  2020-12-28       Impact factor: 4.592

4.  Experimental ischemic stroke induces long-term T cell activation in the brain.

Authors:  Luokun Xie; Wenjun Li; Jessica Hersh; Ran Liu; Shao-Hua Yang
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-10       Impact factor: 6.200

Review 5.  Inflammation and Stroke: An Overview.

Authors:  Josef Anrather; Costantino Iadecola
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 6.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

Review 7.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

Review 8.  Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.

Authors:  Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2017-07-15       Impact factor: 3.969

Review 9.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  Impact of an immune modulator fingolimod on acute ischemic stroke.

Authors:  Ying Fu; Ningnannan Zhang; Li Ren; Yaping Yan; Na Sun; Yu-Jing Li; Wei Han; Rong Xue; Qiang Liu; Junwei Hao; Chunshui Yu; Fu-Dong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.